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                                                                   ABSTRAK 
            Pelbagai usaha telah dilakukan untuk menunjukkan antimikrob dan 
konstituen fitokimia yang terdapat pada tumbuhan ubatan dan menggunakannya 
untuk rawatan pelbagai penyakit sebagai alternatif  kepada drug kimia 
sintetik. Aktiviti antimikrob ekstrak metanol daun, bunga, batang dan akar 
Euphorbia hirta L. diuji dengan beberapa bakteria perubatan penting dan yis dengan 
menggunakan kaedah agar resapan cakera. Empat bakteria Gram positif 
(Staphylococcus aureus, Micrococcus sp., Bacillus subtilis dan Bacillus 
thuringensis), empat bakteria Gram negatif (Escherichia coli, Klebsiella pneumonia, 
Salmonella typhi dan Proteous mirabilis) dan satu yis (Candida albicans) 
disaring. Zon perencatan berkisar antara 9-29 mm. Ekstrak daun menghalang 
pertumbuhan semua mikroorganisma dengan zon perencatan yang luas, diikuti oleh 
bunga, yang menghalang semua bakteria kecuali C. albicans. Mikrob yang paling 
rentan terhadap semua ekstrak adalah S. aureus dan Micrococcus sp. Nilai MIC 
terendah diperolehi daripada E. coli dan C. albicans (3.12 mg/ml), diikuti oleh S. 
aureus (12.50 mg/ml) dan P. mirabilis (50.00 mg/ml). Semua bakteria lain 
mempunyai nilai MIC 100.00 mg/mL. Cerakin bunuh-masa terhadap C. albicans 
menunjukkan kesan fungisida pada 1 dan 2 kali ganda MIC. Kajian mikroskopik 
elektron pengimbasan dan transmisi (SEM dan TEM) ke atas C. albicans 
menunjukkan bahawa sel yang terdedah kepada ekstrak daun memaparkan perubahan 
drastik struktur dalaman dan luaran yang mana ianya semakin teruk dengan 
peningkatan masa rawatan. Analisis GC-MS menunjukkan kehadiran enam sebatian 
berbeza dalam ekstrak daun. Ekstrak E. hirta mempunyai aktiviti antioksidan yang 
signifikan apabila diukur menggunakan DPPH, FRAP, serta penentuar kandungan 
jumlah fenol dan flavonoid. Ekstrak daun E. hirta mempamerkan aktiviti pengautan 
xvi 
 
dengan DPPH maksima 72.96±0.78% pada 1.0 mg/ml diikuti oleh bunga, akar dan 
batang dengan aktiviti 52.45±0.66%, 48.59±0.97% dan 44.42±0.94% masing-
masing. Piawai hidroksitoluena terbutil (BHT) didapati mempunyai 75.13±0.75% 
pada kepekatan yang sama. Kuasa penurunan ekstrak daun adalah setanding dengan 
asid askorbk dan didapati bergantung kepada dos. Kandungan fenol dilaporkan 
sebagai kesetaraan asid galik. Ekstrak daun mempunyai kandungan flavonoid 
tertinggi (206.17±1.95 mg GAE/g), diikuti oleh bunga, akar dan batang yang 
mempunyai 117.08±3.10 mg GAE/g, 83.15 ±1.19 mg GAE/g dan 65.70±1.72 mg 
GAE /g masing-masing. Daun juga mempunyai jumlah kandungan fenol tertinggi 
iaitu 37.97±0.003 mg CE/g, diikuti oleh ekstrak bunga, akar dan batang yang 
mempunyai 35.20±0.002 mg CE/g, 24.35±0.006 mg CE/g dan 24.12±0.004 mg CE/g 
masing-masing. Penyaringan fitokimia ekstrak metanol daun E. hirta menunjukkan 
kehadiran gula penurunan, terpenoid, alkaloid, steroid, tannin, flavonoid serta 
sebatian fenol. Kajian ketoksikan in vitro menunjukkan bahawa daun dan batang E. 
hirta tidak toksik terhadap anak udang air garam sedangkan bunga dan akar adalah 
beracun. Nilai LC50 1.589, 1.420, 0.206 dan 0.0827 mg/ml masing-masing adalah 
diperolehi daripada batang, daun, bunga dan akar. Kajian in vivo ketoksikan akut oral 
pada tikus menunjukkan bahawa ekstrak daun mempunyani LD50 lebih daripada 5000 
mg/kg. Tidak ada kesan toksik yang signifikan ataupun perubahan perilaku yang di 
dapati pada tikus yang dirawat dengan ekstrak daun berbanding dengan kumpulan 
kawalan. Tambahan lagi, analisis histopatologi makroskopik dan mikroskopik organ 
penting daripada tikus rawatan menunjukkan tiada keabnormalan signifikan 
berbanding kawalan. Oleh kerana itu daripada hasil kajian, tumbuhan E. hirta boleh 
digunakan untuk memperolehi bahan bioaktif semulajadi menarik yang boleh 
bertindak sebagai pemula dalam perkembangan farmaseutikal baru. 
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ABSTRACT 
Much work has been done to reveal the antimicrobial and phytochemical 
constituents of medicinal plants and using them for the treatment of various ailments 
as alternatives to chemically synthetic drugs. The antimicrobial activities of the 
methanolic extracts of Euphorbia hirta L. leaves, flowers, stems and roots were 
evaluated against some medically important bacteria and yeast using the agar disc 
diffusion method. Four Gram positive bacteria (Staphylococcus aureus, Micrococcus 
sp., Bacillus subtilis and Bacillus thuringensis), four Gram negative bacteria 
(Escherichia coli, Klebsiella pneumonia, Salmonella typhi and Proteous mirabilis) 
and one yeast (Candida albicans) were screened. Inhibition zones ranged between 
16–29 mm. Leaves extract inhibited the growth of all tested microorganisms with 
large zones of inhibition, followed by flowers, which also inhibited all the bacteria 
except C. albicans. The most susceptible microbes to all extracts were S. aureus and 
Micrococcus sp. The lowest MIC values were obtained from E. coli and C. albicans 
(3.12 mg/ml), followed by S. aureus (12.50 mg/ml) and P. mirabilis (50.00 mg/ml). 
All the other bacteria had MIC values of 100.00 mg/ml. Time-kill assay of
 
C. 
albicans indicated a fungicidal effect at 1 and 2 fold MIC. Scanning and transmission 
electron microscopic studies (SEM and TEM) of
 
C. albicans revealed that cells 
exposed to the leaf extract displayed drastic external and internal structural changes 
which increased with increasing time of treatment. GC-MS analysis indicated the 
presence of six different compounds in the leaf extract. E. hirta extracts had 
significant antioxidant activity when measured using the DPPH, FRAP, and total 
phenolic and flavonoid contents. Leaf extract of E. hirta exhibited a maximum 
DPPH scavenging activity of 72.96 ± 0.78% at 1.0 mg/ml followed by the flowers, 
roots and stems whose scavenging activities were 52.45 ± 0.66%, 48.59 ± 0.97% and 
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44.42 ± 0.94% respectively.  The standard butylated hydroxytoluene (BHT) had a 
scavenging activity of 75.13 ± 0.75% at the same concentration. The IC50 of the 
methanol extract of E. hirta leaves, flowers, roots, stems and BHT were found to be 
0.803 mg/ml, 0.972 mg/ml, 0.989 mg/ml, 1.358 mg/ml and 0.794 mg/ml 
respectively. The reducing power of the leaf extract was comparable with that of 
ascorbic acid and found to be dose dependent. Leaf extract had the highest flavanoid 
content (206.17± 1.95 mg GAE/g), followed by flower, root and stem extracts which 
had 117.08 ± 3.10 mg GAE/g, 83.15 ± 1.19 mg GAE/g and 65.70 ± 1.72 mg GAE/g 
respectively. Leaves also had the highest total phenol content of 37.97 ± 0.003 mg 
CE/g, followed by flower, root and stem extracts which had 35.20 ± 0.002 mg CE/g, 
24.35 ± 0.006 mg CE/g and 24.12 ± 0.004 mg CE/g respectively. Phytochemical 
screening of E. hirta leaf extract revealed the presence of reducing sugars, 
terpenoids, alkaloids, steroids, tannins, flavanoids and phenolic compounds. The in 
vitro toxicity study revealed that the leaves and stems of E. hirta were non toxic 
against the brine shrimp nauplii, whilst flowers and roots were toxic. LC50 values of 
1.589, 1.420, 0.206 and 0.0827 mg/ml were obtained from stems, leaves, flowers and 
roots respectively. The in vivo acute oral toxicity study in mice showed that the leaf 
extract had LD50 of more than 5000 mg/kg. No significant toxic effects or 
behavioural changes appeared on the leaf extract treated mice as compared to the 
untreated groups. Furthermore, the macroscopic and microscopic histopathological 
analysis of the vital organs from the treated mice showed no significant 
abnormalities when compared with the control. Hence, E. hirta could be used to 
discover new bioactive natural products that may serve as leads in the development 
of new pharmaceuticals. 
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CHAPTER ONE 
INTRODUCTION 
 
1.1 General  
 The history of herbal medicines is as old as human civilization. Human has to 
rely on nature in order to survive and sustain. Nature provides a remedy for nearly 
every disease that may afflict a human being. During the ancient times, almost all 
medicines were from natural products. Since the beginning of humankind people 
have depended primarily on plants for nourishment and through trial and error they 
discovered that some plants are good for food, some are poisonous, and some 
produce physiological changes such as increased perspiration, bowel movement, 
fertility, urination, pain relief, hallucination, and healing. By time, these observations 
were passed orally from one generation to another, with each generation adding to 
and refining the body of knowledge (Chah et al., 2006). However, nowadays, the use 
of medicinal plants is well known among the citizens of rural areas of many 
developing countries. While, in the developed countries, 25 percent of the medical 
drugs are derived from plants (Principe, 2005). The World Health Organization 
(WHO) estimates that 80% of the people in developing countries of the world rely on 
traditional medicine for their primary health care needs, and about 85% of traditional 
medicine involves the use of plant extracts (Retnam and Martin, 2006). 
In general, plants are found to be used as medicines or made into medicines 
in five traditional ways: by infusing the herb in water (as teas, infusions, decoctions, 
washes, beers, or steams), by infusing the herb in alcohol or an alcohol-and-water 
combination (tinctures, fluid extracts, and, when diluted, as washes or sprays), by 
transferring the power of the herb to an oil base, by using the plant itself (eaten 
whole, wound powders, in capsules, smoking, or smudging), or by distilling and 
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using the essential oil of the plant (Buhner, 1999). Majority of these extraction 
methods involve the isolation of the active constituents found in a particular 
medicinal plant and its subsequent modification. 
 Euphorbia hirta L. (Euphorbiaceae) is considered as one of the common 
medicinal plants in the tropics and subtropics. Recently, much research is focused on 
Euphorbia species which have been employed as a traditional cure for several 
indications such as gastrointestinal disorders (diarrhea, dysentery, intestinal 
parasitosis, etc), bronchial and respiratory diseases (asthma, cough, bronchitis, hay 
fever) (Bhaskara et al., 2010), in addition to many other uses. Several 
pharmacological properties of E. hirta are reported in literature such as: sedative, 
anxiolytic, analgesic, antipyretic, antiinflammatory (Lanhers et al., 1991), 
antidiarrheic (Galvez et al., 1992), antibacterial (Abubakar, 2009; Doughari et al., 
2008; Ogbulie et al., 2007) and diuretic (Johnson et al., 1999). This plant has also 
been shown to inhibit prostaglandin biosynthesis, platelet aggregation and 
carragenan-induced edema (Hiermann and Bucar, 1994).  
The extraordinary values of E. hirta have attracted attention to investigate its 
natural properties. However, despite the various reports on the curative and 
preventive properties of E. hirta, this is the first time the plant is studied on its 
antimicrobial activities in such detailed manner and as separated parts (leaves, stems, 
flowers and roots).  
 
1.2  Problem Statement 
Despite the huge number of antimicrobial agents already exist for various 
purposes; the search for new drugs should be a continuous one since the target 
microorganisms often develop new genetic variants which subsequently become 
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resistant to available antimicrobial agents. Thus, the effective life span of any 
antibiotic is limited. The world‘s vision is now directing towards plant sources for 
developing antimicrobial drugs, since natural products are rich in secondary 
metabolites that may be used to develop new drugs with novel modes of action. 
According to the World Health Organization (WHO), medicinal plants would be the 
best source to obtain a variety of drugs (Nascimento et al., 2000). Therefore, such 
plants should be investigated to better understand their properties, safety and 
efficacy. There are several reports published on antimicrobial activity of various 
crude plant extracts (Abubakar, 2009; Igoli et al., 2005; Alzoreky and Nakahara, 
2003). It is estimated that there are about 2.5 million species of higher plants and the 
majority of these have not been examined yet for their pharmacological activities 
(Ram et al., 2003).  
 On the other hand, free radicals are usually generated in vivo from various 
biochemical reactions and also from the respiratory chain as a result of occasional 
leakage. However, excessive generation of these radicals that are not effectively 
scavenged by cellular antioxidant constituents may lead to a variety of disorders in 
biological systems including heart diseases, neurodegenerative diseases, cancer, 
diabetes, arthritis, inflammation, lung damage and the aging process itself 
(Ramamoorthy and Bono, 2007). Moreover, free radicals are known to take part in 
lipid peroxidation in foods, which is responsible for rancid odours and flavours that 
decrease the food nutritional value (Walia et al., 2010).  There is an increasing 
interest in antioxidants, particularly in those intended to prevent the presumed 
deleterious effects of free radicals in the human body, and to prevent the 
deterioration of fats and other constituents of foodstuffs. In both cases, there is a 
preference for antioxidants from natural rather than from synthetic sources (Gulcin et 
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al., 2010; Esmaeili and Sonboli, 2010; Wang et al., 2010). Concerns about the safety 
of the commonly used synthetic antioxidants such as butylated hydroxyanisole 
(BHA) and butylated hydroxytoluene (BHT) have led to increase interest in natural 
antioxidants which occur in plants as secondary metabolites (Gulcin et al., 2010). 
Many plants exhibit efficient antioxidant properties owing to their secondary 
metabolities, especially phenolic constituents (Lin et al., 2010).  
 This study may contribute to finding new novel antimicrobial substances to 
control the pathogenic bacteria or C. albicans, especially those that are resistant to 
currently available antibiotics or even find new antioxidants against the destructive 
free radicals. It may also provide a clear image about the plant safety for 
consumption.  
 
1.3        Objectives 
  This study aims to investigate the antibacterial, anticandidal activities of E. 
hirta against four Gram positive and four Gram negative bacteria in addition to C. 
albicans. The antioxidant potential of the plant parts is to be evaluated by DPPH 
radical scavenging, ferric reducing antioxidant power assay, total phenolic and 
flavonoid contents, whereas toxicological studies of the plant are conducted, both in 
vitro (Artemia salina napulii) and in vivo (mice acute oral toxicity). Finally, the 
chemical composition of the bioactive compounds in the most active part is 
determined using phytochemical screening, thin layer chromatography (TLC) and 
gas chromatography-mass spectrometry (GC-MS).  
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1.4       Scope of Research 
 In this study, E. hirta separated parts (leaves, stems, flowers, and roots) will 
be screened for their in vitro antimicrobial, antioxidant activities and their toxicity 
will be evaluated using in vitro and in vivo methods. First, the plant composition will 
be studied using phytochemical screening to determine which secondary metabolites 
are present in the extract. Then, the antimicrobial activity of each part will be 
evaluated against a broad spectrum of bacteria and C. albicans using disc diffusion 
method, to know the most active extract. The lowest concentration of this part extract 
that can inhibit the microbial growth will be determined using the minimal inhibitory 
concentration broth dilution methods. Furthermore; the most susibtible microbe will 
be exposed to extensive studies such as the growth profile, electron microscopy 
observation and the active substances against this microbe will be identified using 
chromatography methods, such as TLC, agar overlay method and GC-MS analysis.  
 For antioxidant activity of E. hirta, four different methods will be used to 
study the antioxidant capacity of the plant parts such as DPPH scavenging, ferric 
reducing antioxidant power assay and the quantitative determination of the phenolic 
and flavonoid contents. This antioxidant activity will be confirmed using the high 
performance thin layer chromatography. 
 Finally, the plant toxicity will be evaluated using the in vitro brine shrimp 
lethality test and the in vivo Swiss albino mice acute oral toxicity test. Both tests will 
provide an idea about the toxicity levels of E. hirta extracts through determination of 
the median lethal concentration (LC50) and median lethal dose (LD50) values 
respectively.  
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CHAPTER TWO 
LITERATURE REVIEW 
 
2.1 Antimicrobial Activity 
2.1.1 Antimicrobial Agents 
 Antibiotic came from the ancient Greek word ―antibios‖ where: anti= 
against, and bios= life. It is a natural or synthetic substance that stops microbes, both 
bacteria and fungi, by killing them or inhibiting their growth (Walsh, 2008). 
Antibiotics are one class of antimicrobials, a larger group which also includes anti-
viral and anti-parasitic drugs. Antimicrobial agents could be biocidal or biostatic. 
The biocidal antimicrobials (bactericidal, fungicidal, virucidal) kill pathogenic 
microorganisms, while the biostatic ones (bacteriostatic, fungistatic) only slow down 
their growth and give the body the chance to use its immune system against the 
microorganisms (Ogundare and Onifade, 2009; Pankeyand Sabath, 2004). 
Antibiotics known as broad-spectrum antibiotics can be used to treat a wide range of 
infections caused by several types of bacteria and are usually used where the specific 
type of the microorganism is unknown. Antibiotics which are only active against 
particular types of Gram positive or Gram negative bacteria are called narrow-
spectrum antibiotics. Antibiotics that target protein synthesis, such as the 
tetracyclines, aminoglycosides, and macrolides, are usually bacteriostatic in nature. 
Those that target the bacterial cell wall (penicillins, cephalosporins), or cell 
membrane (polymixins), or interfere with essential bacterial enzymes 
(sulphonamides, quinolones) are usually bactericidal (Finberg et al., 2004).  
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For a new antibiotic to be an effective chemotherapeutic agent, it should 
satisfy certain requirements, the most important is to be selective against different 
groups of microorganisms. It must have desirable antibacterial properties, that is, it 
must affect bacteria or other microorganisms that are not subject to the action of 
other antibiotics or synthetic chemical compounds, or it must be more potent or more 
effective than others in current use. The antibiotic must also be active in the presence 
of body fluids, not be destroyed by tissue enzymes, not too toxic to animals as a 
whole, or to tissues, or to individual cells. Preferably, the antibiotic should have 
desirable physical and chemical properties, such as solubility in water and a certain 
degree of stability. It has to be excreted readily, but not too fast, from the animal 
system and must not accumulate there and cause undesirable side effects (Todar, 
2002).  
2.1.2 History of Antibiotics 
The first antibiotic was discovered by a British microbiologist, Alexander 
Fleming, in 1928 from a mold called Penicillium notatum. Fleming observed that a 
plate culture of the bacterium Staphylococcus aureus had been contaminated by the 
blue-green mold Penicillium notatum and that colonies of bacteria adjacent to the 
mold were inhibited. Therefore, Fleming grew the mold in a pure culture and found 
that it produced a substance that killed a number of disease-causing bacteria. 
However, the value of Alexander Fleming's discovery was not recognized and the 
use of penicillin did not start until the 1940s when Howard Florey and Ernst Chain 
isolated the active ingredient and prepared a powder form of the antibiotic. Since 
then, antibiotics have been recognized as important chemotherapeutic agents and 
their role in the treatment of numerous diseases became permanently established. 
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More efforts for the production of antibiotics from new sources resulted in the 
isolation of actinomycin from the soil bacteria Actinomycetes in 1940 (Waksman, 
1949). Nowadays, most of the currently available classes of antimicrobial drugs are 
of natural or semisynthetic origins, and only three synthetic classes including the 
sulfa drugs, quinolones and oxazolidinones are in practical use (Walsh, 2003). 
The almost exponential increasing of the total number of discovered bioactive 
microbial compounds in the last decades amazingly became constant. In 1940 only 
10-20, in 1950 around 300-400, in 1960 approximately 800-1000 and in 1970 
already 2500 antibiotics were known. From that time the total number of known 
bioactive microbial metabolites has doubled in each ten years. In 1980 about 5000, in 
1990 around 10000 and in 2000 already almost 20000 antibiotic compounds were 
discovered. By the end of 2002, more than 22000 bioactive secondary metabolites, 
including antibiotics, were published in the literature (Berdy, 2005). Despite the huge 
number of natural antimicrobial products, most of them are already useless because 
they are not specific for bacteria, toxic, too weak, or lack the desired 
pharmacokinetic properties (Pelaez, 2006). From the 22500 known antibiotics and 
similar bioactive microbial compounds, less than one percent which accounts for 
only about 150 compounds, is in direct use in human and veterinary medicine, and 
agriculture. In the human therapy about one hundred compounds, most of them 
derived from Actinomycetales, are in direct practical use (Berdy, 2005). Since 1960s, 
only two new classes of antibiotics have been introduced for use, linezolid in 2000 
and daptomycin in 2003 (Bubnoff, 2006). 
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2.1.3 Action Mechanisms of Antibiotics  
Most antimicrobial agents used for the treatment of bacterial infections may 
be classified according to their principal mechanism of action. The five major modes 
of action are: (1) inhibition of cell wall synthesis, (2) alteration in cell membrane 
permeability, (3) inhibition of ribosomal protein synthesis, (4) suppression of nucleic 
acid (DNA) synthesis, and (5) inhibition of folic acid synthesis. Beta-lactam 
(penicillins, cephalosporins, carbapenems, and monobactams) and glycopeptide 
(vancomycin, teicoplanin) cell wall inhibitors prevent the formation of cross-linking 
steps required for stable cell wall synthesis to prevent micro-organisms from 
maintaining their internal osmotic pressure and consequently causing their lysis. 
Polymyxin B and our natural cationic peptides destruct cell membrane integrity with 
the cationic peptides literally putting pores in the membrane. Ribosomal proteins 
synthesis inhibitors (macrolides, clindamycin, tetracyclines, streptogramins and 
oxazolidinediones) inhibit protein synthesis at various ribosomal receptor sites. Since 
bacterial ribosomes structure differs from those in eukaryotic cells, antibacterial 
agents employ these differences to selectively inhibit bacterial growth. 
Metronidazole and fluorquinolones exert their antibacterial activities by disrupting 
DNA synthesis and producing fatal double-strand DNA breaks during DNA 
replication, while sulfonamides and trimethoprim block successive stages in the 
synthesis of folic acid necessary for the survival of certain bacteria. Disruption of 
bacterial membrane structure may be a fifth mode of action. It is suggested that 
polymyxins exhibit their inhibitory effects by increasing bacterial membrane 
permeability, causing leakage of bacterial contents (Tenover, 2006; Pallasch, 2003). 
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2.1.4 Antibiotic Resistance 
Antibiotic resistance is a natural biological phenomenon where a 
microorganism is able to tolerate exposure to an antibiotic. The use of an 
antimicrobial for any infection, in any dose and for any time period, obligates 
microbes to either die or adapt in a condition known as selective pressure. 
Antimicrobial use kills the susceptible microorganisms but permits the newly 
resistant ones to survive and grow.  Microbes which adapt and survive carry genes 
for resistance (WHO, 2010). Once obtained, resistance genes are not easily lost. 
Instead, they become a relatively stable part of the organism‘s genetic material and 
can be passed on. With time, additional resistance determinants join those currently 
available, thus widening the multidrug resistance (MDR) phenotype and further 
limiting treatment options (Levy, 2005). MDR means resistance to at least three of 
the five main groups of agents currently used for treatment, which include the broad-
spectrum penicillins, broad spectrum cephalosporins, carbapenems, aminoglycosides 
and 4-fluoroquinolones. The terms pan drug resistance (PDR) and extreme or 
extensive drug-resistance (XDR) has also been used where PDR implies resistance to 
all licensed antimicrobial agents, while XDR implies something between MDR and 
PDR (Gould, 2008). 
Bacterial infections which cause most human diseases are also those in which 
emerging and microbial resistance is most evident: diarrhoeal diseases, meningitis, 
respiratory tract infections, sexually transmitted infections, and hospital-acquired 
infections. Some important examples of antibiotic resistant bacteria include 
penicillin-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, 
methicillin-resistant Staphylococcus aureus, multi-resistant salmonella, multi-
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resistant Mycobacterium tuberculosis (WHO, 2010), broad spectrum  ß-lactama 
resistant  K. pneumoniae or E. coli and some cephalosporin resistant species of 
Enterobacteriaceae (Jones and Pfaller, 1998). Additionally, antimicrobial resistance 
is not restricted to only bacteria, resistance development among some fungi, 
particularly those fungi that cause infections in transplant patients with weakened 
immune systems, resistance emergence to common anti-malaria and anti-HIV drugs 
are also of great concerns (WHO, 2010).  
Resistance of microbial pathogens to an increasing number of antibiotics is a 
serious problem (Bubnoff, 2006). It is considered one of the most serious issues in 
hospital  infections, where small but increasing numbers of isolates, mainly Gram-
negative nonfermenters of the genera Acinetobacter and Pseudomonas, are resistant 
to all good antibiotics and where growing numbers of Enterobacteriaceae are 
resistant to all except carbapenems. However, despite there is a lesser decrease of 
agents active against staphylococci, the prevalence of infections with methicillin-
resistant S. aureus (MRSA) remains extensively high in many countries (Livermore, 
2004). For instance, in July 2004, the Infectious Disease Society of America (IDSA) 
reported that 90,000 people of the two million patients, who are infected with 
bacteria in US hospitals annually, have died. Seventy percent of the deaths acquired 
strains that are resistant to at least one of the commonly used antibiotics, especially, 
methicillin-resistant Staphylococcus aureus (Cushnie and Lamb, 2005). At present, 
the antibiotic resistance problem has grown to include all of the major bacterial 
pathogens and all classes of antibiotic compounds worldwide (Barrett, 2005). This 
may mark the end of the antibiotic era; therefore, it is our responsibility as 
researchers to prevent such a trend by searching new sources of antimicrobial agents 
with different mechanisms of action from the already available drugs. 
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2.1.5 Mechanisms of Resistance to Antibacterial Agents 
The normally susceptible bacteria may acquire resistance to antimicrobial 
agents by mutation and selection, or through acquiring the genetic material that 
encodes resistance from other bacteria. Genetic exchange may occur through one of 
various genetic mechanisms including transformation, conjugation or transduction. 
Through genetic exchange mechanisms, many bacteria have become resistant to 
several classes of antibacterial agents. These multidrug resistant bacteria have 
become a cause for serious concern, especially in hospitals and other healthcare 
centres where they tend to occur most commonly (Tenover, 2006). 
Sensitive bacteria may turn resistant to an antimicrobial agent via new 
mutations. Such spontaneous mutations may cause resistance by (1) modification of 
the target protein to which the antibacterial agent binds by altering or eliminating the 
binding site, (2) upregulating the production of enzymes that inactivate the 
antimicrobial agent before it reaches its target site, (3) downregulating or altering an 
outer membrane protein channel that the drug involves to enter the cell, (4) 
upregulating efflux pumps that expel the drug from the cell or (5) development of 
alternate growth requirements  (Tenover, 2006; Pallasch, 2003). In all of these cases, 
strains of bacteria carrying resistance-conferring mutations are selected by 
antimicrobial use, which kills the susceptible strains but allows the newly resistant 
strains to survive and grow. Acquired resistance that develops due to chromosomal 
mutation and selection is called vertical evolution (Tenover, 2006). 
Bacteria also develop resistance through the acquisition of new genetic 
material from other resistant organisms. This is called horizontal evolution, and can 
occur between strains of the same species or between different bacterial species or 
genera. Mechanisms of genetic exchange include conjugation, transduction, and 
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transformation. During conjugation, a gram-negative bacterium transfers plasmid-
containing resistance genes to a nearby bacterium, usually through an elongated 
proteinaceous structure called a pilus, which connects the two organisms. During 
transduction, resistance genes are moved from one bacterial cell to another by 
bacterial viruses or bacteriophages. Conjugation among gram-positive bacteria is 
usually initiated by production of sex pheromones by the mating pair, which ease the 
clumping of donor and recipient organisms, permitting DNA exchange. Lastly, 
transformation can transfer resistance genes into previously susceptible strains when 
bacteria acquire and incorporate DNA segments from other bacteria that have lysed 
and released their DNA complement into the environment. Therefore, mutation and 
selection, together with the mechanisms of genetic material exchange, allow many 
bacterial species to tolerate the introduction of antibacterial agents into the 
environment (Tenover, 2006). 
 
2.1.6 Plants as a Potential Source of New Antibiotics  
Despite previous successes of antibiotic drug discoveries, infectious diseases 
still become the second-leading cause of mortality worldwide. Bacterial infections 
cause 17 million deaths globally, especially in children and elderly people (Butler 
and Buss, 2006). On the other hand, the rapid onset of resistance to most antibacterial 
drugs shortens their effectiveness and necessitates a constant supply of new 
antibiotics with new modes of action for efficient treatment of infections (Butler and 
Buss, 2006; Tenover, 2006). 
Natural products have played a central role in antibiotic drug discovery with 
most antibacterial drugs being derived from a natural product or natural product lead 
(Nascimento et al., 2000). In the last few decades, several reports have been 
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published about the antimicrobial properties of different compounds from herbs and 
spices, fruits and vegetables, leaves and bark, animal tissues and microorganisms. 
Many herbs and spices have been reported to possess significant antimicrobial 
properties, which are due to compounds synthesized in the secondary metabolism of 
the plant (Nascimento et al., 2000). The effective components of plant antimicrobial 
phytochemicals include alkaloids, flavones (flavonoids, flavonols, and quinones), 
essential oils, lectins, polypeptides, phenolics, polyphenols, tannins and terpenoids 
(Samy and Gopalakrishnakone, 2008).  
Flavonoids have been reported to possess numerous therapeutic properties, 
including antimicrobial, antioxidant, anti-inflammatory, enzyme inhibition, 
oestrogenic, antiallergic, vascular and cytotoxic antitumour activities (Cushnie and 
Lamb, 2005). Interesting effects of oleuropein, the main glycoside present in olives, 
has been shown against both Gram negative and Gram-positive bacteria as well as 
mycoplasma (Omar, 2010). Oleuropein and hydrolysis products are able to inhibit 
the development and production of enterotoxin B by Staphylococcus aureus, the 
development of Salmonella enteritidis and the germination and consequent 
development of Bacillus cereus spores. Oleuropein and other phenolic compounds 
(p-hydroxybenzoic, vanillic and p-coumaric acids) also completely inhibit the 
development of K. pneumoniae, E. coli and B. cereus. Recent studies showed the 
antimicrobial activity of commercial Olea europaea (olive) leaf extracts (mainly 
oleuropein) against Campylobacter jejuni, Helicobacter pylori and methicillin-
resistant Staphylococcus aureus (MRSA) (Omar, 2010). Despite the wide 
antimicrobial activity, the exact mechanism of action of oleuropein is still not 
completely established. However, some authors have suggested that it may be due to 
the presence of the ortho-diphenolic system (catechol), the ability of the glycoside 
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group of oleuropein to modify and penetrate the cell membrane and reaches the 
target site, the effective interference with the production procedures of particular 
amino acids necessary for the growth of certain microorganisms or the direct 
stimulation of phagocytosis as a response of the immune system to microbes of all 
types (Omar, 2010).  
This and other studies suggest screening of plant extracts and/or their 
phytochemicals for antimicrobial properties as a great source for developing new 
promising antimicrobial agents. More efforts in this field may lead to significant 
discovery of novel antibiotics to replace the existing ones to whom most bacteria 
became resistant. 
 
2.1.7  Evaluation of Antimicrobial Susceptibility 
 
There are various techniques that are widely used in screening plants for 
antimicrobial activity. Although a variety of methods exist, the goal of all the in vitro 
antimicrobial susceptibility testing methods is to measure the inhibitory effect of the 
antimicrobial agent and to provide a reliable predictor of how an organism is likely 
to respond to antimicrobial therapy in vivo. The common antimicrobial test methods 
are agar diffusion, agar dilution and broth dilution.  In order to be effective, an in 
vitro susceptibility testing technique has to be reproducible, accurate and reliable, but 
not time-consuming, expensive or tedious. 
 
2.1.7.1 Agar Diffusion Method 
This is a qualitative method that is divided into disc diffusion and well 
diffusion methods which can be performed according to the properties of the 
substances to be tested. The disc diffusion method also known as the Kirby-Bauer 
16 
 
disc-diffusion, or the zone of inhibition method, is probably the most widely used 
method for testing antibacterial activity, because it uses only small amounts of the 
test substance (10–30 μL). It can be performed with minimal training. Briefly, the 
method involves the preparation of a Petri dish containing 15–25 ml agar; and 
microorganism at a known concentration is then spread across the agar surface and 
allowed to establish for 10-30 min. A filter paper disc of 6 - 8 mm diameter, 
containing a known volume of the test substance is then applied on the agar surface 
and the dish incubated for 24 h or more. Discs should be evenly distributed so that 
zones of inhibition do not overlap to such a degree that the zone of inhibition 
diameter cannot be determined. This can be obtained if the discs are not less than 24 
mm far from centre to centre. On the other hand, when the extract is viscous or semi-
solid such as honey, a well can be made in the agar and the substance allowed to 
diffuse out of the well instead of away from a disc. Generally, the compound diffuses 
into the agar. The diffusion of the antimicrobial agent into the seeded agar media 
results in a gradient of the antimicrobial agent. The concentration of the compound 
will be highest next to the disc/well, and will decrease as distance from the disc/well 
increases. If the compound is effective against bacteria at a certain concentration, a 
clear area of no colonies will grow where the concentration in the agar is greater than 
or equal to the effective concentration. Thus, the size of the zone of inhibition is a 
measure of the compound's effectiveness: the larger the clear area, the more effective 
the compound. Data from these assays are typically presented as a mean size of zone 
of inhibition (mm), a ranking system of +, ++, and +++ or slight/ moderate/ strong, 
and sensitive/ intermediate/ resistant, to indicate levels of activity. Agar diffusion test 
ought to be standardized since the zone size is affected by many factors such as 
inoculum size, medium composition, temperature of incubation, excess moisture and 
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thickness of the agar. If these conditions are controlled, reproducible tests can be 
achieved and zone diameter is only a function of the test organism susceptibility 
(OIE, 2008).  
2.1.7.2 Agar Dilution Method 
Agar dilution method is a quantitative method, being used to determine the 
lowest concentration of the assayed antimicrobial agent (minimal inhibitory 
concentration, MIC) that, under defined test conditions, inhibits the visible growth of 
the bacterium being tested. MIC values are used to determine susceptibilities of 
bacteria to drugs and also to evaluate the activity of new antimicrobial agents. In this 
method the antimicrobial agent of known concentrations is added into the agar at two 
fold serial dilution and, once set, bacteria are applied to its surface. Replicate dishes 
can be set up with a range of concentrations of the test substance. In this way, a large 
number of bacteria may be screened within a single assay run. The dishes are 
incubated for 24 hrs or more and the growth of the bacteria on the extract/agar mix is 
scored either as present, absent, or a percentage of inhibition as a proportion of the 
control (e.g. 0, 25%, 50%, 75%, 100%). No growth of the test organism indicates 
that it is susceptible at the antimicrobial concentration incorporated into the medium 
(OIE, 2008; Wiegand et al., 2008). Agar dilution is often recommended by 
the Clinical and Laboratory Standards Institute (CLSI) as a standardised 
antimicrobial susceptibility method for fastidious organisms, such as anaerobes, 
Campylobacter and Helicobacter species (OIE, 2008).  
 
 
2.1.7.3 Broth Dilution Method  
 Broth dilution is a technique in which a suspension of microorganism of an 
appropriate concentration is tested against varying concentrations of an antimicrobial 
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agent in a liquid medium. The broth dilution method usually uses serial twofold 
dilutions and can be performed either in tubes containing a minimum volume of 2.0 
ml (macrodilution) or in smaller volumes using microtitration plates (microdilution) 
(OIE, 2008). Serial dilutions of the antimicrobial agent are made in a liquid medium 
which is inoculated with a standardized number of organisms and incubated for a 
prescribed time. The lowest concentration of antibiotic preventing appearance of 
turbidity is considered to be the minimal inhibitory concentration (MIC). At this 
dilution the antimicrobial agent is microstatic. Also, the minimal 
bactericidal/fungicidal concentration (MBC/MFC) can be determined by 
subculturing some of the tube contents onto antibiotic-free agar medium and 
examining for microbial growth.  Despite, the tube dilution test is fairly precise, the 
test is laborious because serial dilutions of the antimicrobial agent must be prepared 
and only one isolate can be tested in each series of dilutions (Ncube et al., 2008). In 
contrast, the microdilution method appears to be more applicable since it gives 
reproducible results, requires only small volumes of extract to determine minimal 
inhibitory concentrations and works well with fungi. This method is useful in 
screening plants for antimicrobial activity and for the bioassay-guided isolation of 
antimicrobial compounds from plants (Ahmad et al., 2006). 
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2.2 Candida  
Candida is thin-walled, small yeast of 4 to 6 microns that reproduces by 
budding (Spencer and Spencer, 1997). It is an asexual dimorphic organism and can 
exist in two shapes and forms simultaneously. One form is a yeast-like state that is a 
non-invasive and sugar fermenting organism. The other is the invasive fungal form 
that produces very long root-like structures, called rhizoids which can penetrate the 
mucosa (McCullough et al., 1996).  
The genus Candida includes between 150 and 200 species. Amongst these, 
seven are most commonly isolated in human infections. They are divided into two 
broad categories; albicans and non-albicans species. C. albicans is the most abundant 
and significant species, due to its ability to adhere to host tissues, to produce aspartyl 
proteases and phospholipase enzymes, and to transformate from yeast to hyphal 
phase, the major determinants of its pathogenicity. Candida glabrata, Candida 
tropicalis, Candida stellatoidea, Candida parapsilosis, Candida krusei, and Candida 
kyfer are also isolated as causative agents of Candida infections (Kikani et al., 2008; 
McCullough et al., 1996).  Due to the relatively high DNA homology between C. 
albicans and C. stellatoidea, the second has been reclassified as a sucrose negative 
variant of C. albicans (McCullough et al., 1996). 
Candida can be found on or in the human body with the gastrointestinal tract, 
the vagina, and skin being the common sites, and C. albicans being the most 
common species isolated from these locations (Kikani et al., 2008). Candida is also 
counted as the most common cause of opportunistic mycoses worldwide. The 
infections caused by all species of Candida are called candidiasis, and are the fourth 
most causable of nosocomial blood stream infections associated with a significant 
mortality (Pfaller and Diekema, 2007). One of the main reasons for the increase in 
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Candida infections is the development of its resistant strains to azole drugs, such as 
fluconazole used in the prophylaxis and treatment of candidiasis (Bhavan et al., 
2010). Therefore considerable interest in the screening for new anticandidal agents 
would be useful in the diagnosis and treatment of Candida infections. 
On the other hand, the formation of Candida biofilms carries significant 
clinical importance because of their increased resistance to antifungal therapy and the 
ability of cells within biofilms to tolerate host immune defenses. C. albicans in 
biofilms on polyvinyl chloride disks has been reported to be 30 to 2,000 times more 
resistant to antifungal agents than free-floating cells (Bachmann et al., 2002).  
 C. albicans biofilm formation usually involves the presence of implantable 
devices and has three developmental phases; early phase that requires the adherence 
of yeast cells to the host cells or device surface, intermediate phase with the 
formation of a matrix with dimorphic switching from yeast to hyphal forms, and 
maturation phase where increase in the matrix material taking on a three-dimensional 
architecture takes place. Fully mature Candida biofilms contain a mixture of 
morphological forms and composed of a dense network of yeasts, hyphae, and 
pseudohyphae in a matrix of polysaccharides, carbohydrate, protein and unknown 
constituents (Ramage et al., 2005, 2001; Kojic and Darouiche, 2004). 
 
 
2.2.1 Candida albicans 
 C. albicans is a dimorphic organism that commonly inhabits in 
gastrointestinal tract of human beings, oral and vaginal mucosa as one of the 
commensal organisms. It causes opportunistic infections in immunocompromised 
patients, and produces allergic reactions (Naglik et al., 2003). It also causes a variety 
of infections ranging from non-life threatening mucosal candidiasis like vaginal yeast 
